离心机 丙烯酰胺 PCR 凝胶过滤
名称: 重组人血管内皮生长抑制因子(VEGI-192) 
地域: 江苏 
有效期: 2009-09-15 00:00:00.0 -- 2009-09-14 
发布时间: 2009-09-14 23:20:26.0 
点击查看大图联系商家进入展台
加载中,请稍等...
产品详情:

重组人血管内皮生长抑制因子
目录号规格价格
C038A2ug600元
C038B10ug1200元
C038C50ug3980元
*大包装请询价
Background:

IVascular endothelial growth inhibitor (VEGI; TNFSF-15) is a new member of the tumor necrosis factor family. VEGI is predominantly an endothelial cell-specific gene, and recombinant VEGI is a potent inhibitor of endothelial cell proliferation, angiogenesis and tumor growth. VEGI exerts two activities on endothelial cells: early G1 arrest of G0/G1-cells responding to growth stimuli, and programmed death of proliferating cells. These activities are highly specific to endothelial cells. VEGI is also able to regulate the expression of several important genes involved in angiogenesis. These findings are consistent with the view that VEGI functions as an autocrine cytokine to inhibit angiogenesis and stabilize the vasculature.

Description:

Recombinant human VEGI-192 produced in E. coli is a single, non-glycosylated polypeptide chain containing 192 amino acids and having a molecular mass of 21858 Dalton.

Quality Control:
Biological activity: The ED50 as determined by the dose-dependant inhibition of the proliferation of HUVEC (HumanUmbilical Vein Endothelial Cells) is less then 5µg/ml.
Purity: Greater than 95.0% as determined by:
         (a) Analysis by RP-HPLC.
         (b) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel.
Amino-Acid Sequence: The sequence of the first five N-terminal amino acids was determined and was found to be Met-Gln-Leu-Thr-Lys.
Endotoxin: Less than 0.1 ng/µg (1 IEU/µg) of rHuVEGI.
 
Formulation:
The protein was lyophilized after extensive dialysis against 0.5M NaCl, 50mMTris-HCl buffer, pH 7.5.
Storage:
Lyophilized VEGI-192 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C.
Upon reconstitution VEGI-192 should be stored at 4°C between 2-7 days and for future use below -18°C. For longterm storage it is recommended to add a carrier protein (0.1% HSA or BSA).

        Please avoid freeze-thaw cycles.

Reconstitution:

It is recommended to reconstitute the lyophilized VEGI-192 in sterile 18MΩ-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions.
      For laboratory in vitro research use only.


版权所有 2007-2010 北京百奥知信息科技有限公司 京ICP备08004458号
客户服务电话:010-82790317 010-82790315
邮箱:support@bioknow.cn